XML 57 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Discontinued Operations (Tables)
 12 Months Ended
Dec. 31, 2019
Summary of Assets and Liabilities Held for Sale and Operating Results Related to Discontinued Operations Assets and liabilities related to discontinued operations or held for sale as of December 31, 2018 consisted of the following:

 

 

December 31,

2018

 

Assets

 

 

 

 

Current assets held for sale:

 

 

 

 

Accounts receivable, net

 

$

108

 

Inventory, net

 

 

2,841

 

Other current assets

 

 

328

 

 

 

$

3,277

 

Long-term assets held for sale:

 

 

 

 

Property and equipment, net

 

 

260

 

Other noncurrent assets

 

 

1,866

 

Goodwill

 

 

3,550

 

Intangible assets, net

 

 

5,957

 

 

 

 

11,633

 

Total assets

 

$

14,910

 

 

 

 

 

 

Liabilities

 

 

 

 

Current liabilities held for sale:

 

 

 

 

Accounts payable and accrued liabilities

 

$

580

 

Long-term liabilities held for sale:

 

 

 

 

Other noncurrent liabilities

 

 

78

 

Deferred revenues

 

 

167

 

Noncurrent liabilities

 

$

245

 

Total liabilities

 

$

825

 

 

The following table summarizes the results of discontinued operations for the periods presented (in thousands).

 

 

 

Year ended December 31,

 

 

 

2019

 

 

2018

 

Product revenue

 

$

901

 

 

$

2,671

 

License revenue

 

 

—

 

 

 

1,000

 

Total revenues

 

 

901

 

 

 

3,671

 

Cost of revenue

 

 

857

 

 

 

2,373

 

Gross profit

 

 

44

 

 

 

1,298

 

Operating expenses:

 

 

 

 

 

 

 

 

Research and development

 

 

656

 

 

 

3,099

 

Sales and marketing

 

 

411

 

 

 

1,375

 

General and administrative

 

 

185

 

 

 

760

 

Total operating expenses

 

 

1,252

 

 

 

5,234

 

Operating loss

 

 

(1,208

)

 

 

(3,936

)

Other income (expense)

 

 

112

 

 

 

180

 

Loss from discontinued operations

 

$

(1,096

)

 

$

(3,756

)

Loss from sale of business

 

 

(6,508

)

 

 

—

 

Net loss from discontinued operations

 

$

(7,604

)

 

$

(3,756

)

Included in the statement of cash flows are the following non-cash adjustments related to the discontinued operations (in thousands):

 

 

 

For the year ended December 31,

 

 

 

2019

 

 

2018

 

Depreciation and amortization

 

$

467

 

 

$

1,625

 

Provision for excess inventory

 

$

—

 

 

$

463

 

Loss on asset disposal

 

$

—

 

 

$

(36

)
Discontinued Operations Disposed of By Sale [Member]  
Summary of Business Consideration to Calculation of the Loss on Sale  The following table summarizes the calculation of the loss on sale of the Cell Therapy business, which was finalized during the fourth quarter of 2019 (in thousands):

Consideration received

 

$

7,000

 

Transaction costs

 

 

(1,363

)

Net cash proceeds

 

 

5,637

 

Less:

 

 

 

 

Carrying value of business and assets sold

 

 

12,145

 

Net loss on sale of business

 

$

(6,508

)